Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,994 | -28,995 | -15,980 | -64,790 | -52,105 |
| Depreciation Amortization | 14,195 | 9,558 | 4,580 | 17,668 | 13,643 |
| Accounts receivable | 967 | 9,055 | 4,730 | -2,075 | 3,195 |
| Accounts payable and accrued liabilities | 4,996 | 3,136 | 3,124 | 787 | 605 |
| Other Working Capital | -2,127 | 5,762 | 4,660 | -13,597 | -10,124 |
| Other Operating Activity | 5,279 | -5,601 | -5,409 | 26,797 | 15,095 |
| Operating Cash Flow | $-11,684 | $-7,085 | $-4,295 | $-35,210 | $-29,691 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,010 | -1,671 | -1,030 | -2,531 | -2,031 |
| Net Acquisitions | 5,997 | -5,154 | -5,154 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -62,370 | -52,719 |
| Sale Of Investment | 36,810 | 34,411 | 23,644 | 25,600 | 16,000 |
| Investing Cash Flow | $40,797 | $27,586 | $17,460 | $-39,301 | $-38,750 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 55,000 | N/A |
| Debt Repayment | 0 | N/A | N/A | -51,826 | N/A |
| Common Stock Issued | 21,321 | 645 | N/A | 2,133 | 1,690 |
| Other Financing Activity | -896 | -637 | -503 | -2,517 | -684 |
| Financing Cash Flow | $20,425 | $8 | $-503 | $2,790 | $1,006 |
| Exchange Rate Effect | 86 | -205 | -331 | 56 | -5 |
| Beginning Cash Position | 23,736 | 23,736 | 23,736 | 95,401 | 95,401 |
| End Cash Position | 73,360 | 44,040 | 36,067 | 23,736 | 27,961 |
| Net Cash Flow | $49,624 | $20,304 | $12,331 | $-71,665 | $-67,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,684 | -7,085 | -4,295 | -35,210 | -29,691 |
| Capital Expenditure | -2,010 | -1,671 | -1,030 | -2,531 | -2,031 |
| Free Cash Flow | -13,694 | -8,756 | -5,325 | -37,741 | -31,722 |